Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, October 9, 2023
[ Mon, Oct 09th 2023
] - WOPRAI
[ Mon, Oct 09th 2023
] - WOPRAI
[ Mon, Oct 09th 2023
] - WOPRAI
[ Mon, Oct 09th 2023
] - WOPRAI
[ Mon, Oct 09th 2023
] - WOPRAI
[ Mon, Oct 09th 2023
] - WOPRAI
[ Mon, Oct 09th 2023
] - WOPRAI
[ Mon, Oct 09th 2023
] - WOPRAI
[ Mon, Oct 09th 2023
] - WOPRAI
[ Mon, Oct 09th 2023
] - WOPRAI
[ Mon, Oct 09th 2023
] - WOPRAI
[ Mon, Oct 09th 2023
] - WOPRAI
Fri, October 6, 2023
[ Fri, Oct 06th 2023
] - WOPRAI
[ Fri, Oct 06th 2023
] - WOPRAI
[ Fri, Oct 06th 2023
] - WOPRAI
[ Fri, Oct 06th 2023
] - WOPRAI
[ Fri, Oct 06th 2023
] - WOPRAI
[ Fri, Oct 06th 2023
] - WOPRAI
[ Fri, Oct 06th 2023
] - WOPRAI
[ Fri, Oct 06th 2023
] - WOPRAI
[ Fri, Oct 06th 2023
] - WOPRAI
[ Fri, Oct 06th 2023
] - WOPRAI
[ Fri, Oct 06th 2023
] - WOPRAI
[ Fri, Oct 06th 2023
] - WOPRAI
[ Fri, Oct 06th 2023
] - WOPRAI
[ Fri, Oct 06th 2023
] - WOPRAI
[ Fri, Oct 06th 2023
] - WOPRAI
[ Fri, Oct 06th 2023
] - WOPRAI
[ Fri, Oct 06th 2023
] - WOPRAI
Jayson Bedford Maintained (ANGO) at Buy with Decreased Target to $12 on, Oct 6th, 2023
Jayson Bedford of Raymond James, Maintained "AngioDynamics, Inc." (ANGO) at Buy with Decreased Target from $13 to $12 on, Oct 6th, 2023.
Jayson has made no other calls on ANGO in the last 4 months.
There are 2 other peers that have a rating on ANGO. Out of the 2 peers that are also analyzing ANGO, 0 agree with Jayson's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Jayson
- William Plovanic of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $17 on, Thursday, October 5th, 2023
- Yi Chen of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $20 on, Thursday, October 5th, 2023
